From August 14-18, 2024, the 19th Asian Society for Neuro-Oncology (ASNO) annual meeting was held in Singapore, bringing together top specialists from around the world to discuss the latest research in neuro-oncology.
Author
Harutyun Papoyan
Pathologist
From HistoGen lab, we had a pathologist Harutyun Papoyan representing us at this prestigious event, providing an excellent platform for sharing knowledge on the diagnosis and management of brain tumors.
One of the most impactful sessions was a full day dedicated to neuropathology, where leading experts presented in-depth case studies on gliomas and meningiomas. These presentations highlighted the diagnostic complexities of these tumors, focusing on differential diagnosis through molecular profiling techniques.
Gliomas, often challenging to diagnose, were the subject of several detailed case presentations. Speakers presented how novel genetic markers are aiding in distinguishing these tumors from other central nervous system lesions. For meningiomas, a range of clinical cases was shared, covering various grades and the diagnostic challenges they pose, particularly in distinguishing benign forms from more aggressive variants.
Our lab’s pathologist had the opportunity to meet with prominent neuropathologists from Japan, India, Hong Kong, and Singapore. These interactions fostered discussions on clinical cases, diagnostics, and emerging trends in the field, paving the way for potential research collaborations.
The knowledge and experience gained at the ASNO 2024 conference have enriched our lab’s approach to neuro-oncology research, particularly in understanding the subtleties of diagnosing gliomas and meningiomas. We look forward to incorporating these insights into our ongoing work and building on the connections made during the event.
We would like to extend our heartfelt thanks to Ibrahim Qaddoumi, MD, MS and St. Jude hospital for the opportunity to participate in this incredible event and contribute to the future of neuropathology.
